Cargando…
Clinical and genetic characterization of NIPA1 mutations in a Taiwanese cohort with hereditary spastic paraplegia
OBJECTIVE: NIPA1 mutations have been implicated in hereditary spastic paraplegia (HSP) as the cause of spastic paraplegia type 6 (SPG6). The aim of this study was to investigate the clinical and genetic features of SPG6 in a Taiwanese HSP cohort. METHODS: We screened 242 unrelated Taiwanese patients...
Autores principales: | Fang, Shih‐Yu, Chou, Ying‐Tsen, Hsu, Kuo‐Chou, Hsu, Shao‐Lun, Yu, Kai‐Wei, Tsai, Yu‐Shuen, Liao, Yi‐Chu, Tsai, Pei‐Chien, Lee, Yi‐Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014004/ https://www.ncbi.nlm.nih.gov/pubmed/36607129 http://dx.doi.org/10.1002/acn3.51724 |
Ejemplares similares
-
Clinical characteristics of Taiwanese patients with Hereditary spastic paraplegia type 5
por: Chou, Cheng‐Ta, et al.
Publicado: (2020) -
Biallelic
DDHD2
mutations in patients with adult‐onset complex hereditary spastic paraplegia
por: Chou, Ying‐Tsen, et al.
Publicado: (2023) -
The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling
por: Tsang, Hilda T.H., et al.
Publicado: (2009) -
High frequency of SPG4 in Taiwanese families with autosomal dominant hereditary spastic paraplegia
por: Lan, Min-Yu, et al.
Publicado: (2014) -
Clinical and Genetic Features of Chinese Patients With NIPA1-Related Hereditary Spastic Paraplegia Type 6
por: Fu, Jun, et al.
Publicado: (2022)